Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Healthcare Biotechnology
Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

Recent & Breaking News (TSX:MBX)

Microbix Completes Multiple Facility Upgrades

GlobeNewswire May 8, 2018

Microbix to Present at Bloom Burton Conference

GlobeNewswire April 30, 2018

Microbix Announces Annual and Special Meeting Voting Results

GlobeNewswire April 2, 2018

Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Directors

GlobeNewswire March 19, 2018

Microbix Featured at Cantech Investment Conference

GlobeNewswire January 29, 2018

Microbix Expands Quality Assessment Product Family

Marketwired January 18, 2018

Microbix Reports Full Year and Fourth Quarter Results

Marketwired December 21, 2017

Microbix Confirms Ramp-up of Production

MarketWire Canada November 27, 2017

Microbix Completes Second Tranche of Brokered Private Placement

Marketwired October 27, 2017

Microbix Completes Brokered Private Placement

MarketWire Canada October 19, 2017

Microbix Announces End of Legal Dispute

Marketwired October 11, 2017

Microbix Announces First Shipment of Bioreactor Antigen

Marketwired September 13, 2017

Microbix to Amend Share Purchase Warrant Terms

MarketWire Canada August 24, 2017

Microbix Reports Record Third Quarter & Nine Month Sales

MarketWire Canada August 14, 2017

Microbix Announces Expanded Customer Supply Agreement

Marketwired August 8, 2017

Microbix Announces Leadership Transition

MarketWire Canada July 24, 2017

Microbix Reports Strong First Half Sales Growth

MarketWire Canada May 15, 2017

Microbix Consults with FDA Regarding Plans for Kinlytic(R) Urokinase

Marketwired May 1, 2017

Microbix Announces Amendments to Debenture and Share Purchase Warrants

MarketWire Canada April 28, 2017

Microbix Announces Annual Meeting Voting Results

MarketWire Canada March 30, 2017